There has been news from the US about the Corona epidemic in the world amidst the chaos. Immunization programs may begin soon in the US. It has been informed by the White House that the work of applying Kovid-19 vaccine can start in the country from 11 or 12 December.
Also Read: Trump to announce Plasma Treatment Authorized for COVID-19
Pfizer asked for the emergency use of the vaccine
On Friday, US pharmaceutical company Pfizer and its German partner BioNotech applied to the US Food and Drug Administration (FDA) to seek emergency permission for their Kovid-19 vaccine. The FDA vaccine advisory committee is scheduled to meet on 10 December. There may be a decision on this. Dr. Monsef Slau, head of the Corona Virus Vaccination Program in the US,
will deliver vaccines to
the centers in 24 hours. “We plan to bring the vaccines to the vaccination centers within 24 hours of the approval, so I think two days after the approval After 11 or 12 December the vaccination program will start.
The vaccine is 95 percent effective
This vaccine has been developed by American company Pfizer and BioNotech. This vaccine has been found to be 95 percent effective. According to reports, Pfizer has stated the price of one dose of this drug in the US at $ 20, or about 1500 rupees.
Over 1.20 million infected people
tell that America is badly affected by Corona. According to Johns Hopkins University, total corona cases in the United States have crossed 1 million and 20 million, while the virus has killed more than 2.5 lakh patients so far.
